Antimicrobial Agents and Chemotherapy · 2006 · 55 citations · 20 references
PharmacyPharmacokineticsPharmacologyDrug ClearancePharmacokinetic ModelingPopulation PharmacokineticsAge-related Pharmacokinetic DifferencesNonlinear Mixed-effects ModelingPediatric PharmacokineticsPediatric PharmacologyPopulation Pharmacokinetic ModelingSex-based Pharmacokinetic DifferencesAge-dependent PharmacokineticsChild PharmacokineticsPediatric Pharmacokinetic ModelingPediatric Population PharmacokineticsPharmacokinetics In InfancyPlasma Clearance EstimationRate ConstantsSex-related Pharmacokinetic Differences
The pharmacokinetics of lopinavir were investigated by the use of a population approach performed with the nonlinear mixed effect modeling program NONMEM and 157 children ranging in age from 3 days to 18 years. The pharmacokinetics of lopinavir were well described by a one-compartment model in which the absorption and the elimination rate constants were equal. Typical population estimates of the apparent volume of distribution (V/F) and plasma clearance (CL/F) were 24.6 liters and 2.58 liters/h, respectively. The lopinavir V/F and CL/F were both related to body weight (BW), with an important increase in weight-normalized CL/F for the lowest BW. Combined treatment with lopinavir and nevirapine was found to increase the CL/F. The lopinavir CL/F was also age and sex related, as a 39% increase was observed after the age of 12 years for boys compared to the CL/F for girls. The consequences of these pharmacokinetic discrepancies and the necessity to modify the currently recommended dosage regimen should be further investigated.
20